ASSET BRANDING

In the highly regulated world of pharmaceutical assets, a brand must be as precise as the science behind it. This collection features three medication brands my team and I recently brought to market. For each asset, we developed a cohesive ecosystem designed to scale—ranging from initial logo ideation and strategic color palettes to the production of commercial-scale packaging. These projects demonstrate our ability to integrate creative storytelling and FDA/EMA compliance, ensuring that every
touchpoint—from brand guidelines to supporting clinical collateral—is both impactful and regulatory-sound.